Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carcinogens in Electronic Cigarette Users (CANICE)
NCT02897401Unknown
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Sep 2016
- Primary completion
- Nov 2017
- Countries
- 1
01
Overview
Open-label trial, sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Urinary N'-nitrosonornicotine concentration. Status: unknown.
Beyond the preview
Go deeper on NCT02897401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02897401.